title: Progression to cancer in Barrett's esophagus is associated with genomic instability.
abstract: Barrett's esophagus is a condition in which metaplastic columnar epithelium replaces squamous esophageal epithelium as a consequence of chronic gastroesophageal reflux. Patients with this condition are at increased risk for the development of adenocarcinoma. To better understand the progression to adenocarcinoma in this disease, we studied abnormalities in DNA content of epithelial cells in Barrett's esophagus. Using flow cytometry, we examined the spatial distribution of abnormal nuclear DNA contents (aneuploidy) in the esophagi of 14 patients with Barrett's adenocarcinoma. Multiple (2 to 14) populations of aneuploid cells were seen in 12 of the 14 cases. Some early carcinomas appeared to be associated with a single aneuploid population of cells. Surrounding dysplastic epithelium often contained multiple, different overlapping aneuploid populations. These data suggest that neoplastic progression in Barret's esophagus is associated with a process of genomic instability which leads to evolution of multiple aneuploid populations, with the ultimate development of a clone of cells capable of malignant invasion. Thus, detection of multiple aneuploid populations of cells in Barrett's esophagus may indicate a high risk of cancer. Barrett's esophagus provides a unique and readily accessible model for the study of neoplastic progression in human epithelial malignancy.
authors.affiliation: Department of Pathology, University of Washington, Seattle.
authors.forename: P S
authors.initials: PS
authors.lastname: Rabinovitch
authors.forename: B J
authors.initials: BJ
authors.lastname: Reid
authors.forename: R C
authors.initials: RC
authors.lastname: Haggitt
authors.forename: T H
authors.initials: TH
authors.lastname: Norwood
authors.forename: C E
authors.initials: CE
authors.lastname: Rubin
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000235:genetics / Q000473:pathology; D000782:Aneuploidy; D001471:Barrett Esophagus / Q000150:complications* / Q000235:genetics / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis*; D004938:Esophageal Neoplasms / Q000209:etiology* / Q000235:genetics / Q000473:pathology; D005434:Flow Cytometry; D006801:Humans; D011446:Prospective Studies
chemical_list: D004273:DNA, Neoplasm